Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repair
线粒体 microRNA (mitomiRs) 在内源性肾修复中的作用
基本信息
- 批准号:10471652
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-17 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAttenuatedBiogenesisBiological AssayCell NucleusCell physiologyCellsCharacteristicsCytosineCytosolDataDeteriorationDevelopmentDioxygenasesDiseaseElderlyEnd stage renal failureEnhancersEnzymesEpigenetic ProcessEpithelial CellsExhibitsFamily suidaeFibrosisFunctional ImagingFunctional disorderGene ExpressionGene SilencingGenesGenetic TranscriptionHarvestHistonesHypertensionImaging TechniquesImpairmentIn VitroInflammationInfusion proceduresInjury to KidneyKidneyKidney DiseasesMeasuresMediatingMethylationMicroRNAsMitochondriaMitochondrial DNAMorbidity - disease rateNucleic Acid Regulatory SequencesOxidation-ReductionPhenotypePolyribonucleotide NucleotidyltransferasePopulationProcessProductionProliferatingProtein ImportRegulator GenesRenal Artery StenosisRenal functionRibonuclease IIIRoleStructural defectStructureSystemTechniquesTestingTubular formationUntranslated RNAcell injuryclinically relevantexperimental studygenome-wideimprovedin vivoinhibitor/antagonistinjuredinsightkidney repairmigrationmortalitynovelnovel strategiesoxidationparacrineporcine modelpreservationprogenitorpromoterprotective effectrenal ischemiarepairedreparative capacitytool
项目摘要
Renal artery stenosis (RAS) remains a common cause of hypertension and end-stage renal disease in the
elderly population, associated with increased morbidity and mortality. Recent data suggest that renal ischemia
in RAS interferes with endogenous kidney repair mechanisms, such as CD133+/CD24+ scattered tubular-like
cells (STCs), which can proliferate and their progeny re-differentiate into tubular epithelial cells to replace lost
neighboring injured tubular cells. Our previous studies have shown that experimental RAS impairs the
reparative capacity of swine STCs by inducing structural and functional abnormalities in their mitochondria.
However, the processes underpinning RAS-induced STC mitochondrial damage remain unclear.
Micro-RNAs (miRNAs) are non-coding RNA fragments that function as post-transcriptional regulators of
gene expression. MiRNA genes are transcribed in the nucleus, which results in the production of pri- and pre-
miRNA precursors, and subsequently mature miRNAs. Although most mature miRNAs are present in the
cytosol, few miRNAs, known as ‘mitomiRs’, translocate to the mitochondrion to silence gene expression related
to mitochondrial functions.
Our preliminary data show that RAS increases expression of mitomiRs in swine STCs, associated with
decreased expression of mitochondrial DNA (mtDNA) genes, and in turn mitochondrial structural abnormalities
and dysfunction. Our pilot experiments also show that the promoters and enhancers of mitomiRs exhibit hyper
5-hydroxymethylation of cytosine (5hmC), an epigenetic mark generated by the oxidation of 5mC by the ten-
eleven translocation methylcytosine dioxygenase (TET). Possibly, renal ischemia in RAS may alter mitomiR
biogenesis and interfere with mitochondrial function in STCs. This might be partly mediated by epigenetic
processes (5hmC) within mitomiR regulatory regions and/or increased import of mitomiRs into mitochondria.
The working hypothesis underlying this proposal is that altered mitomiR expression in STCs underlies
RAS-induced STC mitochondrial damage, blunting the paracrine function and capacity of STCs to
preserve the post-stenotic kidney. Three specific aims will be pursued: Aim 1: will test whether increased
mitomiR expression in RAS-STCs induces mitochondrial structural damage and dysfunction in STCs. Aim 2:
will test whether RAS imposes epigenetic changes that increase mitomiR expression in STCs. Aim 3: will test
whether aberrant mitomiR mitochondrial import contributes to STC dysfunction. Successful studies will provide
novel insight into the vulnerability of this repair system and may contribute towards development of feasible
clinically relevant tools for improving the utility and efficacy of kidney repair in renal disease.
肾动脉狭窄(RAS)仍然是高血压和终末期肾病的常见原因。
老年人口,与发病率和死亡率增加有关。最近的数据表明,肾脏缺血
RAS干扰内源性肾脏修复机制,如CD133+/CD24+散在小管样
可以增殖的细胞(STCs)及其后代重新分化为肾小管上皮细胞以取代丢失的细胞
邻近受损的肾小管细胞。我们之前的研究表明,实验性的RAS损害了
通过诱导线粒体结构和功能异常来提高猪干细胞的修复能力。
然而,RAS诱导STC线粒体损伤的过程尚不清楚。
MicroRNAs(MiRNAs)是一种非编码的RNA片段,其功能是转录后调节
基因表达。MiRNA基因在细胞核中转录,这导致Pri-和Pre-DNA的产生
MiRNA前体,以及随后成熟的miRNAs。尽管大多数成熟的miRNAs存在于
在胞浆中,少数miRNAs被称为“有丝分裂受体”,移位到线粒体以抑制相关基因的表达。
线粒体的功能。
我们的初步数据显示,RAS增加了猪STCs中有丝分裂受体的表达,与
线粒体DNA(MtDNA)基因表达减少,进而导致线粒体结构异常
和功能障碍。我们的初步实验还表明,有丝分裂受体的启动子和增强子表现出高度的
胞嘧啶的5-羟甲基化(5hmC),一种表观遗传标记,由5 mC被10-HmC氧化而产生-
转位甲基胞嘧啶双加氧酶(Tet)11例。RAS肾缺血可能改变有丝分裂原受体
STCs的生物发生和干扰线粒体功能。这可能在一定程度上是由表观遗传调节的。
在有丝分裂受体调节区内的过程(5hmC)和/或增加有丝分裂受体进入线粒体。
支持这一提议的工作假设是,STC中丝裂原受体表达的改变是
RAS诱导STC线粒体损伤,钝化STC的旁分泌功能和能力
保留狭窄后的肾脏。将追求三个具体目标:目标1:将测试是否增加
RAS-STCs中丝裂原受体的表达可导致STCs线粒体结构损伤和功能障碍。目标2:
将测试RAS是否会施加表观遗传变化,从而增加STC中有丝分裂受体的表达。目标3:意志测试
线粒体的异常输入是否导致STC功能障碍。成功的研究将提供
对此修复系统的脆弱性的新见解,并可能有助于开发可行的
提高肾脏修复在肾脏疾病中的实用性和有效性的临床相关工具。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alfonso Eirin其他文献
Alfonso Eirin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alfonso Eirin', 18)}}的其他基金
Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repair
线粒体 microRNA (mitomiRs) 在内源性肾修复中的作用
- 批准号:
10583380 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Obesity-induced dysfunction of human MSC in peripheral microvascular repair
肥胖引起的人间充质干细胞在外周微血管修复中的功能障碍
- 批准号:
10516515 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Obesity-induced dysfunction of human MSC in peripheral microvascular repair
肥胖引起的人间充质干细胞在外周微血管修复中的功能障碍
- 批准号:
10653231 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Mitochondrial injury interferes with endogenous renal repair in experimental renovascular disease
线粒体损伤干扰实验性肾血管疾病的内源性肾修复
- 批准号:
9805789 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
A potential role for mitoprotection in preserving the kidney in metabolic syndrome and renal artery stenosis
有丝分裂保护在代谢综合征和肾动脉狭窄中保护肾脏的潜在作用
- 批准号:
9115146 - 财政年份:2015
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant